[Previous Months][Date Index][Thread Index][Join - Register][Login]
[Message Prev][Message Next][Thread Prev][Thread Next]

[IP] Gluco Watch

FDA review of Cygnus blood sugar monitor set Dec 6


REDWOOD CITY, Calif., Oct. 27  Cygnus Inc. (NASDAQ:CYGN) said on Wednesday
that its watch-like device that allows diabetics to continuously check their
blood sugar will be reviewed by a U.S. Food and Drug Administration (FDA)
advisory committee on Dec. 6.

In July, the FDA told Redwood City, Calif.-based Cygnus that its application
to market the device, known as a GlucoWatch monitor, would be granted
expedited review.

The monitor allows adult patients to painlessly check their blood sugar, or
glucose, levels every 20 minutes. It would replace currently used finger-prick
blood tests and have the potential to help manage diabetes better, the company

The GlucoWatch monitor also has the capability to alert users when glucose
levels are too high or too low.

The device uses a battery to generate a small current which changes the size
of pores in the skin, through which fluid seeps out, comes in contact with the
device, and is measured electrochemically.

Diabetes, which affects more than 15 million Americans, is a serious disease
that can lead to complications including heart disease, blindness and stroke.

In June, the FDA approved the sale of another glucose monitoring device, made
by diabetes control company MiniMed Inc. (NASDAQ:MNMD), which is inserted
underneath the skin.

 This message sent to you from the desk of
  Yerachmiel Bruchya haLevi Altman's computer.

The contents of this message have never been read, none-the-less
checked for validity, truth or political correctness.

All correspondence about this letter should be sent to the author's
mommy who will scold him if need be


for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml